http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png
Virotherapy in Germany—Recent Activities in Virus Engineering, Preclinical Development, and Clinical Studies
Nettelbeck, D. (First author)DKFZ* ; Leber, M. F.DKFZ* ; Altomonte, J. ; Angelova, A. L.DKFZ* ; Beil, J.DKFZ* ; Berchtold, S. ; Delic, M. ; Eberle, J. ; Ehrhardt, A. ; Engeland, C.DKFZ* ; Fechner, H. ; Geletneky, K. ; Goepfert, K. ; Holm, P. S. ; Kochanek, S. ; Kreppel, F. ; Krutzke, L. ; Kühnel, F. ; Lang, K. S. ; Marchini, A.DKFZ* ; Moehler, M. ; Mühlebach, M. D. ; Naumann, U. ; Nawroth, R. ; Nüesch, J.DKFZ* ; Rommelaere, J.DKFZ* ; Lauer, U. M.DKFZ* ; Ungerechts, G. (Last author)DKFZ*
2021
MDPI
Basel
This record in other databases:

Please use a persistent id in citations: doi:10.3390/v13081420
Note: #EA:F230#LA:F230# / #DKFZ-MOST-Ca184#
Contributing Institute(s):
- KKE Virotherapie (F230)
- DKTK Koordinierungsstelle Tübingen (TU01)
- LOVIT (F011)
- Virus-assoziierte Karzinogenese (F170)
Research Program(s):
- 316 - Infektionen, Entzündung und Krebs (POF4-316) (POF4-316)
Appears in the scientific report
2021
Database coverage:
;

;

; Article Processing Charges ; BIOSIS Previews ; Biological Abstracts ; Clarivate Analytics Master Journal List ; DOAJ Seal ; Ebsco Academic Search ; Essential Science Indicators ; Fees ; IF < 5 ; JCR ; PubMed Central ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection